RT Journal Article
SR Electronic
T1 Causal effects of maternal circulating amino acids on offspring birthweight: a Mendelian randomisation study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.15.22273911
DO 10.1101/2022.04.15.22273911
A1 Zhao, Jian
A1 Stewart, Isobel D
A1 Baird, Denis
A1 Mason, Dan
A1 Wright, John
A1 Zheng, Jie
A1 Gaunt, Tom R
A1 Evans, David M
A1 Freathy, Rachel M
A1 Langenberg, Claudia
A1 Warrington, Nicole M
A1 Lawlor, Deborah A
A1 Borges, Maria Carolina
A1 ,
YR 2022
UL http://medrxiv.org/content/early/2022/04/18/2022.04.15.22273911.abstract
AB Amino acids are key to protein synthesis, energy metabolism, cell signaling and gene expression; however, the contribution of specific maternal amino acids to fetal growth is unclear. We explored the effect of maternal circulating amino acids on fetal growth, proxied by birthweight, using two-sample Mendelian randomization and summary data from a genome-wide association study (GWAS) of serum amino acids levels (sample 1, n = 86,507) and a maternal GWAS of offspring birthweight, adjusting for fetal genotype effects (sample 2, n = 406,063 with maternal and/or fetal genotype effect estimates). A total of 106 independent single nucleotide polymorphisms (SNPs) robustly associated with 19 amino acids (p < 4.9 × 10−10) were used as genetic instrumental variables. Our results provide evidence that maternal circulating glutamine (59 g offspring birthweight increase per SD increase in maternal amino acid level, 95% CI: 7, 110) and serine (27 g, 95% CI: 9, 46) raise, while leucine (−59 g, 95% CI: -106, -11) and phenylalanine (−25 g, 95% CI: -47, -4) lower offspring birthweight. Our findings strengthen evidence for key roles of maternal circulating amino acids in healthy fetal growth.Competing Interest StatementDAL has received support from Medtronic Ltd and Roche Diagnostics for research unrelated to this study.Funding StatementThis study was supported by the US National Institute of Health (R01 DK10324), the European Research Council under the European Union Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no 669545, British Heart Foundation (CS/16/4/32482 and AA/18/7/34219), and the NIHR Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol; the latter provided JZ salary whilst working on this study. Born in Bradford is funded by the Wellcome Trust (223601/Z/21/Z and WT101597MA) a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) (MR/N024397/1), the British Heart Foundation (CS/16/4/32482) and the National Institute for Health Research (NIHR) under its Collaboration for Applied Health Research and Care (CLAHRC) for Yorkshire and Humber and the Clinical Research Network (CRN). JZ, DAL, MCB, RMF, TRG, DB, J Zheng and DME work in / are affiliated with a unit that is supported by the University of Bristol and UK Medical Research Council (MC_UU_00011/4 and MC_UU_00011/6). DAL is supported by a British Heart Foundation Chair (CH/F/20/90003) and an NIHR Senior Investigator (NF-0616-10102). R.M.F. is supported by a Wellcome Senior Research Fellowship (WT220390). This research was funded in part, by the Wellcome Trust [Grant number WT220390]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any author accepted manuscript version arising from this submission. MCB was supported by a UK Medical Research Council (MRC) Skills Development Fellowship (MR/P014054/1). J Zheng is supported by the Academy of Medical Sciences (AMS) Springboard Award, the Wellcome Trust, the Government Department of Business, Energy and Industrial Strategy (BEIS), the British Heart Foundation and Diabetes UK (SBF006\1117).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval for BiB has been obtained from the Bradford Research Ethics Committee. Written consent was obtained from all participants. Cambridge Local Research Ethics Committee approved the Fenland study, and this study only used its summary level data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.